Comparative Assessment of uNGAL, uNAG and Cystatin C As Early Biomarkers in Renal Post-Transplant Patients

1. Perico N, Cattaneo D, Sayegh MH, Remuzzi G. Delayed graft function in kidney transplantation. Lancet, 2004, 364, No. 9447, 1814-1827.10.1016/S0140-6736(04)17406-0Search in Google Scholar

2. Ojo AO, Wolfe RA, Held PJ et al. Delayed graft function: risk factors and implications for renal allograft survival. Transplantation, 1997, 63, No. 7, 968-974.10.1097/00007890-199704150-000119112349Search in Google Scholar

3. Koning OHJ, van Bockel JH, van der Woude FJ et al. Risk factors for delayed graft function in University of Wisconsin solution preserved kidneys from multiorgan donors. Transplantation Proceedings, 1995, 27, No.1, 752-753.Search in Google Scholar

4. Sellers MT, Gallichio MH, Hudson SL et al. Improved outcomes in cadaveric renal allografts with pulsatile preservation. Clinical Transplantation, 2000, 14, No. 6, 543-549.10.1034/j.1399-0012.2000.140605.x11127306Search in Google Scholar

5. Gjertson DW. Impact of delayed graft function and acute rejection on kidney graft survival. Clinical Transplants, 2000, 467-480.Search in Google Scholar

6. Yarlagadda SG, Coca SG, Garg AX et al. Marked variation in the definition and diagnosis of delayed graft function: a systematic review. Nephrology Dialysis Transplantation, 2008, 23, No. 9, 2995-3003.10.1093/ndt/gfn158272730218408075Search in Google Scholar

7. Boom H, Mallat MJK, De Fijter JW et al. Delayed graft function influences renal function, but not survival. Kidney International, 2000, 58, No. 2, 859-866.10.1046/j.1523-1755.2000.00235.x10916111Search in Google Scholar

8. Giral-Classe M, Hourmant M, Cantarovich D et al. Delayed graft function of more than six days strongly decreases long-term survival of transplanted kidneys. Kidney International, 1998, 54, No. 3, 972-978.10.1046/j.1523-1755.1998.00071.x9734625Search in Google Scholar

9. Lu CY, Penfield JG, Kielar ML et al. Hypothesis: is renal allograft rejection initiated by the response to injury sustained during the transplant process. Kidney International, 1999, 55, No. 6, 2157-2168.10.1046/j.1523-1755.1999.00491.x10354265Search in Google Scholar

10. Shoskes DA, Cecka JM. Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection. Transplantation, 1998, 66, No. 12, 1697-1701.10.1097/00007890-199812270-000229884262Search in Google Scholar

11. Troppmann C, Gillingham KJ, Gruessner RWG et al. Delayed graft function in the absence of rejection has no long-term impact. A study of cadaver kidney recipients with good function at 1 year after transplantation. Transplantation, 1996, 61, No. 9, 1331-1337.10.1097/00007890-199605150-000088629292Search in Google Scholar

12. Mehta RL, Chertow GM. Acute renal failure definitions and classification: time for change? Journal of the American Society of Nephrology, 2003, 14, No. 8, 2178-2187.10.1097/01.ASN.0000079042.13465.1A12874474Search in Google Scholar

13. Bolignano D, Coppolino G, Lacquaniti A, Buemi M. From kidney to cardiovascular diseases: NGAL as a biomarker beyond the confines of nephrology. European Journal of Clinical Investigation, 2010, 40, No. 3, 273-276.10.1111/j.1365-2362.2010.02258.x20415702Search in Google Scholar

14. Mori K, Lee HT, Rapoport D et al. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. Journal of Clinical Investigation, 2005, 115, No. 3, 610-621.10.1172/JCI2305654831615711640Search in Google Scholar

15. Mishra J, Qing MA, Prada A et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary bio-marker for ischemic renal injury. Journal of the American Society of Nephrology, 2003, 14, No. 10, 2534-2543.10.1097/01.ASN.0000088027.54400.C6Search in Google Scholar

16. Parikh CR, Jani A, Mishra J et al. Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. American Journal of Transplantation, 2006, 6, No. 7, 1639-1645.10.1111/j.1600-6143.2006.01352.x16827865Search in Google Scholar

17. Mishra J, Ma Q, Kelly C et al. Kidney NGAL is a novel early marker of acute injury following transplantation. Pediatric Nephrology, 2006, 21, No. 6, 856-863.10.1007/s00467-006-0055-016528543Search in Google Scholar

18. Malyszko J, Malyszko JS, Mysliwiec M. Serum neutrophil gelatinase-associated lipocalin correlates with kidney function in renal allograft recipients. Clinical Transplantation, 2009, 23, No. 5, 681-686.10.1111/j.1399-0012.2009.01034.x19708926Search in Google Scholar

19. Malyszko J, Malyszko JS, Bachorzewska-Gajewska H et al. Neutrophil gelatinase-associated lipocalin is a new and sensitive marker of kidney function in chronic kidney disease patients and renal allograft recipients. Transplantation Proceedings, 2009, 41, No. 1, 158-161.10.1016/j.transproceed.2008.10.08819249502Search in Google Scholar

20. Lebkowska U, Malyszko J, Lebkowska A et al. Neutrophil gelatinase-associated lipocalin and cystatin C could predict renal outcome in patients undergoing kidney allograft transplantation: a prospective study. Transplantation Proceedings, 2009, 41, No. 1, 154-157.10.1016/j.transproceed.2008.10.09219249501Search in Google Scholar

21. Kusaka M, Kuroyanagi Y, Mori T et al. Serum neutrophil gelatinase-associated lipocalin as a predictor of organ recovery from delayed graft function after kidney transplantation from donors after cardiac death. Cell Transplantation, 2008, 17, No. 1-2, 129-134.10.3727/00000000878390711618472448Search in Google Scholar

22. Hollmen ME, Kyllönen LE, Inkinen KA et al. Urine neutrophil gelatinase-associated lipocalin is a marker of graft recovery after kidney transplantation. Kidney International, 2011, 79, No. 1, 89-98.10.1038/ki.2010.35120861824Search in Google Scholar

23. Hollmen ME, Kyllönen LE, Inkinen KA et al. Deceased donor neutrophil gelatinase-associated lipocalin and delayed graft function after kidney transplantation: a prospective study. Critical Care, 2011, 15, No. 3, article R121.10.1186/cc10220321897421545740Search in Google Scholar

24. Hall IE, Yarlagadda SG, Coca SG et al. IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation. Journal of the American Society of Nephrology, 2010, 21, No. 1, 189-197.10.1681/ASN.2009030264279927619762491Search in Google Scholar

25. Bataille A, Abbas S, Semoun O et al. Plasma neutrophil gelatinase-associated lipocalin in kidney transplantation and early renal function prediction. Transplantation, 2011, 92, No. 9, 1024-1030.10.1097/TP.0b013e318230c07921956199Search in Google Scholar

26. Magnusson NE, Hornum M, Jorgensen KA et al. Plasma neutrophil gelatinase associated lipocalin (NGAL) is associated with kidney function in uraemic patients before and after kidney transplantation. BMC Nephrology, 2012, 13, article 8.10.1186/1471-2369-13-8329662122325322Search in Google Scholar

27. Kusaka M, Iwamatsu F, Kuroyanagi Y et al. Serum neutrophil gelatinase associated lipocalin during the early postoperative period predicts the recovery of graft function after kidney transplantation from donors after cardiac death. Journal of Urology, 2012, 187, No. 6, 2261-2267.10.1016/j.juro.2012.01.03322503046Search in Google Scholar

28. Premaratne E, MacIsaac RJ, Finch S et al. Serial measurements of cystatin c are more accurate than creatinine-based methods in detecting declining renal function in type 1 diabetes. Diabetes Care, 2008, 31, No. 5, 971-973.10.2337/dc07-158818319326Search in Google Scholar

29. Stevens LA, Coresh J, Schmid CH et al. Estimating GFR using serum cystatin C alone and in Combination with serum creati-nine: a pooled analysis of 3,418 individuals with CKD. American Journal of Kidney Diseases, 2008, 51, No. 3, 395-406.10.1053/j.ajkd.2007.11.018239082718295055Search in Google Scholar

30. Perkins BA, Nelson RG, Ostrander BEP et al. Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study. Journal of the American Society of Nephrology, 2005, 16, No. 5, 1404-1412.10.1681/ASN.2004100854242991715788478Search in Google Scholar

31. Laterza OF, Price CP, Scott MG. Cystatin C: an improved estimator of glomerular filtration rate? Clinical Chemistry, 2002, 48, No. 5, 699-707.10.1093/clinchem/48.5.699Search in Google Scholar

32. Cowland JB, Sørensen OE, Sehested M, Borregaard N. Neutrophil gelatinase-associated lipocalin is up-regulated in human epithelial cells by IL-1 beta, but not by TNF-α. Journal of Immunology, 2003, 171, No. 12, 6630-6639.10.4049/jimmunol.171.12.663014662866Search in Google Scholar

33. Devarajan P. Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury. Biomarkers in Medicine, 2010, 4, No. 2, 265-280.10.2217/bmm.10.12289314820406069Search in Google Scholar

34. Jung K, Diego J, Scholz D et al. Urinary enzyme excretion by renal-transplant recipients in relation to interval after transplantation. Clinical Chemistry 1982;28(2):1762-1764.10.1093/clinchem/28.8.1762Search in Google Scholar

35. Marchewka Z, Kuzniar J, Dlugosz A. Enzymatic markers of cyclosporine nephrotoxicity in patients after renal transplantation. Int Urol Nephrol 1999;31:727-34.10.1023/A:1007181126577Search in Google Scholar

36. Skálová S. the diagnostic role of urinary n-acetyl-β β-dglucosaminidase (NAG) activity in the detection of renal tubular impairment. ACTA MEDICA (Hradec Králové) 2005;48(2):75-80.10.14712/18059694.2018.35Search in Google Scholar

37. Burne-Taney MJ, Yokota N, Rabb H. Persistent renal and extrarenal immune changes after severe, ischemic injury. Kidney Int 67: 1002-1009. Cecka JM 2002, The UNOS Renal Transplant Registry. Clin Transpl, 2005, 1-20.10.1111/j.1523-1755.2005.00163.x15698438Search in Google Scholar

38. Cosio FG, Grande JP, Larson TS et al. Kidney allograft fibrosis and atrophy early after living donor transplantation. Am J Transplant, 2005, 5: 1130-1136.10.1111/j.1600-6143.2005.00811.x15816896Search in Google Scholar

39. Doi K, Katagiri D, Negishi K et al. Mild elevation of urinary biomarkers in prerenal acute kidney injury. Kidney Int, 2012, 82: 1114-11120.10.1038/ki.2012.26622854644Search in Google Scholar

40. Domański L, Kłoda K, Pawlik A et al Correlation between ICAM1 and VCAM1 gene polymorphisms and histopathological changes in kidney allograft biopsies. Arch Med Sci, 2013, 9: 276-282.10.5114/aoms.2012.29218364881023671438Search in Google Scholar